COMMUNIQUÉS West-GlobeNewswire

Daré Bioscience, Inc. Expands Leadership Team, Appointing Mary Jarosz, RPh, to Global Head of Regulatory Affairs

04/06/2018 - 14:00

SAN DIEGO, June 04, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a clinical-stage, women’s biopharmaceutical company, today announced the appointment of Mary Jarosz, RPh, to the newly created role of [...]

Cocrystal Pharma Announces Nasdaq Closing Bell Ceremony

04/06/2018 - 14:00

ATLANTA, GA and BOTHELL, WA, June 04, 2018 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (NASDAQ: COCP), (“Cocrystal” or the “Company”), a clinical stage biotechnology company discovering and developing novel antiviral [...]

Novo Nordisk A/S - Share repurchase programme

04/06/2018 - 13:16

Bagsværd, Denmark, 4 June 2018 - On 4 May 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR), [...]

Aptose Announces Two Publications of Preclinical Data Elucidating the Anticancer Mechanism of Action of APTO-253

04/06/2018 - 13:04

Identification of APTO-253 target leading to inhibition of MYC expression in AML and hypersensitivity of cancer cells with BRCA1/2 deficiencies SAN DIEGO and TORONTO, June 04, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences [...]

Avalon GloboCare Appoints Former Deputy Secretary of the U.S. Department of Health and Human Services Dr. Tevi Troy to its Board of Directors

04/06/2018 - 13:00

FREEHOLD, N.J, June 04, 2018 (GLOBE NEWSWIRE) -- Avalon GloboCare Corp. (OTCQB:AVCO), a leading global developer of cell-based technologies, announced today that the Company has appointed Dr. Tevi Troy, Former Deputy [...]

NexoBrid® Receives Marketing Authorization From South Korea’s Ministry of Health

04/06/2018 - 13:00

Exclusive distributor BL&H Co., Ltd. plans commercial launch in second half of 2018 YAVNE, Israel, June 04, 2018 (GLOBE NEWSWIRE) -- MediWound Ltd. (Nasdaq:MDWD), a fully-integrated biopharmaceutical company [...]

Assembly Biosciences to Participate in Jefferies 2018 Global Healthcare Conference

04/06/2018 - 13:00

INDIANAPOLIS and SAN FRANCISCO, June 04, 2018 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (NASDAQ:ASMB), a clinical-stage biotechnology company advancing a new class of oral therapeutics for the treatment of [...]

Results of Kamada’s Phase 2 Trial of Alpha-1 Antitrypsin in Newly Diagnosed Type-1 Diabetes Patients to be Presented at the Upcoming American Diabetes Association’s 78th Scientific Sessions

04/06/2018 - 13:00

REHOVOT, Israel, June 04, 2018 (GLOBE NEWSWIRE) -- Kamada Ltd. (Nasdaq:KMDA) (TASE:KMDA), a plasma-derived protein therapeutics company, today announced that the results from the Company’s Phase 2 trial of Alpha-1 [...]

AMAG Pharmaceuticals Announces FDA Acceptance of New Drug Application Filing for Bremelanotide

04/06/2018 - 13:00

WALTHAM, Mass., June 04, 2018 (GLOBE NEWSWIRE) -- AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) for bremelanotide, [...]

Athenex Announces Poster Presentations at ASCO Annual Meeting

04/06/2018 - 13:00

BUFFALO, N.Y., June 04, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (Nasdaq:ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of [...]

AxoGen, Inc. Appoints Kaila Krum Vice President, Investor Relations and Corporate Development

04/06/2018 - 13:00

ALACHUA, Fla., June 04, 2018 (GLOBE NEWSWIRE) -- AxoGen, Inc. (NASDAQ:AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerves, today announced the appointment of Kaila Krum [...]

CLS and Exact Imaging Sign MoU on Commercial Collaboration Targeting Micro-Ultrasound Guided Laser Ablation Products for Prostate Treatments

04/06/2018 - 13:00

FRAMINGHAM, Mass., June 04, 2018 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (CLS) (publ) and Exact Imaging have signed a memorandum of understanding to enter into a commercial collaboration to jointly optimize [...]

Scholar Rock Announces Exercise in Full and Closing of Over-Allotment Option in Initial Public Offering

04/06/2018 - 13:00

CAMBRIDGE, Mass., June 04, 2018 (GLOBE NEWSWIRE) -- Scholar Rock (NASDAQ:SRRK), a biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which [...]

Acasti Pharma Appoints Brian Groch as Chief Commercial Officer

04/06/2018 - 13:00

LAVAL, Québec, June 04, 2018 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (NASDAQ:ACST) (TSX-V:ACST) (the “ Company ” or “ Acasti Pharma ”), a biopharmaceutical innovator focused on the research, development and [...]

Dova Pharmaceuticals Announces Publication of Pivotal Phase 3 Data and Upcoming Congress Presentations for DOPTELET® (avatrombopag)

04/06/2018 - 13:00

DURHAM, N.C., June 04, 2018 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) today announced the recent online publication of its pivotal Phase 3 trial data on the use of DOPTELET® (avatrombopag) for the [...]

Easton Pharmaceuticals Announces That Revenue Generating Operations Have Commenced From Its Alliance Property and Businesses

04/06/2018 - 13:00

TORONTO, ON, June 04, 2018 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals Inc. (OTC: EAPH) is pleased to announce that revenue generating operations have commenced on its Alliance Group property and businesses. Easton’s JV [...]

ProQR Announces Presentations at ECFS on Eluforsen for F508del Cystic Fibrosis and at CFF Research Conference

04/06/2018 - 13:00

LEIDEN, The Netherlands, June 04, 2018 (GLOBE NEWSWIRE) -- ProQR Therapeutics N.V. (Nasdaq:PRQR), a company dedicated to changing lives through the creation of transformative RNA medicines for the treatment of severe [...]

Zenith Announces Further Advancement of Clinical Trial with ZEN-3694, a Proposed Equity Offering and an Update Webcast

04/06/2018 - 13:00

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, June 04, 2018 (GLOBE NEWSWIRE) -- Zenith Capital Corp. ("Zenith" or the "Company") today announced that [...]

Neuralstem’s NSI-566 stem cell therapy confers neurological improvement in spinal cord injury patients with complete paraplegia

04/06/2018 - 13:00

- Neuralstem Announces Publication of Data From First-In-Human Study of Human Neural Stem Cell Transplantation for Chronic Spinal Cord Injury - - First cohort of four subjects with thoracic (T2-T12) ASIA-A grade spinal [...]